4.7 Letter

Eculizumab impairs killing of Neisseria meningitidis serogroup B in atypical hemolytic uremic syndrome patients vaccinated with MenB-4C

Journal

KIDNEY INTERNATIONAL
Volume 101, Issue 6, Pages 1293-1295

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.kint.2022.03.010

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available